Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
- NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_assertion description "[Increased expression of MDR1, MRP5 and SMRP mRNA was observed 48 hr after the initiation of Adriamycin exposure in human lung cancer PC-14 cells and cisplatin-resistant PC-14/CDDP cells, in a dose-dependent manner as measured by TaqMan real-time RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
- NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_assertion evidence source_evidence_literature NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
- NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_assertion SIO_000772 11745426 NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
- NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_assertion wasDerivedFrom befree-20140225 NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
- NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_assertion wasGeneratedBy ECO_0000203 NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP185277.RA9T7A9syGOYF6lBwNA93C4bsRFqRFMtUczHhL_ZzgZjk130_provenance.